1. Home
  2. CSR vs DAWN Comparison

CSR vs DAWN Comparison

Compare CSR & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSR
  • DAWN
  • Stock Information
  • Founded
  • CSR 1970
  • DAWN 2018
  • Country
  • CSR United States
  • DAWN United States
  • Employees
  • CSR N/A
  • DAWN N/A
  • Industry
  • CSR Real Estate Investment Trusts
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSR Real Estate
  • DAWN Health Care
  • Exchange
  • CSR Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • CSR 1.1B
  • DAWN 1.2B
  • IPO Year
  • CSR N/A
  • DAWN 2021
  • Fundamental
  • Price
  • CSR $64.29
  • DAWN $7.61
  • Analyst Decision
  • CSR Buy
  • DAWN Strong Buy
  • Analyst Count
  • CSR 8
  • DAWN 7
  • Target Price
  • CSR $72.43
  • DAWN $32.29
  • AVG Volume (30 Days)
  • CSR 81.2K
  • DAWN 1.1M
  • Earning Date
  • CSR 04-28-2025
  • DAWN 05-05-2025
  • Dividend Yield
  • CSR 4.79%
  • DAWN N/A
  • EPS Growth
  • CSR N/A
  • DAWN N/A
  • EPS
  • CSR N/A
  • DAWN N/A
  • Revenue
  • CSR $260,983,000.00
  • DAWN $131,161,000.00
  • Revenue This Year
  • CSR $4.61
  • DAWN $26.74
  • Revenue Next Year
  • CSR $4.15
  • DAWN $68.48
  • P/E Ratio
  • CSR N/A
  • DAWN N/A
  • Revenue Growth
  • CSR N/A
  • DAWN N/A
  • 52 Week Low
  • CSR $54.90
  • DAWN $7.52
  • 52 Week High
  • CSR $76.16
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • CSR 51.43
  • DAWN 31.95
  • Support Level
  • CSR $63.18
  • DAWN $7.93
  • Resistance Level
  • CSR $65.48
  • DAWN $8.29
  • Average True Range (ATR)
  • CSR 1.50
  • DAWN 0.42
  • MACD
  • CSR 0.01
  • DAWN 0.07
  • Stochastic Oscillator
  • CSR 70.42
  • DAWN 6.57

About CSR D/B/A Centerspace

Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: